Pfizer (PFE) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY24 Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.79 -0.04%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $1.06, $0.44 better than the analyst estimate of $0.62. Revenue for the quarter came in at $17.7 billion versus the consensus estimate of $14.92 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.75-$2.95, versus the consensus of $2.65. Pfizer sees FY2024 revenue of $61-64 billion, versus the consensus of $61.2 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
